Company intelligence / Profile preview

Hexia

Wuxi, Jiangsu, Chinahexia.app ↗

Ownership: Private
Employees: ~30
Development stage: Other

Overview

Hexia operates as a major exporter and manufacturer of pharmaceutical raw materials, APIs, biologics including vaccines and blood products for both human and veterinary use. The company is active globally with significant export volume but does not appear to have its own proprietary clinical-stage drug development programs.

Therapeutic areas: Other
Modalities: Small moleculeBiologic (including vaccines, blood products, therapeutic biologics)
Industry: Contract Manufacturing Organization

Partnerships

Represents over 1500 domestic pharmaceutical/chemical enterprises as regional or exclusive sales agentClose collaboration with LEVI GROUP for international representation

Beyond the preview

Go deeper on Hexia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hexia.

Explore the full profile